Different Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)

NCT05410457 · tracked via the Priya Life Science China tracker

Sponsor

Nanjing First Hospital, Nanjing Medical University

Phase

Observational

Started

2022-05-24

Last updated

2026-04-09

Condition(s) studied

Ischemic Stroke

Study summary

AISDTS is a prospective registry study, in which clinical information, examination and imaging data of patients with acute ischemic stroke receiving different treatment strategies were collected, grouped and statistically analyzed, and corresponding clinical prediction models were constructed to explore the role of clinical biological indicators in the occurrence and development of stroke.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * A) ≥18 years of age; B) hospital admission for ischemic stroke; C) Signed informed consent. Exclusion Criteria: * A) patients with incomplete clinical information; B) hospitalization observation time less than 24 hours; C) recent trauma, severe inflammation, severe liver and kidney dysfunction, progressive malignance and other serious diseases; D) baseline mRS score\>2; E) informed consent is not signed.

Primary outcome measure(s)

To assess the changes of prognosis of stroke patients under different treatment strategies — 3 months, 6 months, 12 months or 24 months
assessed by The Modified Rankin Score (mRS) of stroke patients \[mild to wores ranging from 0 to 5, 6 represents death\].
To assess the early neurological changes of ischemic stroke — 7 days or 14 days
change from baseline National Institute of Health stroke scalescore (NIHSS) \[higher scores mean worse conditions\]7 days or 14 days

Trial sites (1)

Facility	City	Region	Status
Nanjing First Hospital, Nanjing Medical University	Nanjing	Jiangsu	Recruiting

More Nanjing First Hospital, Nanjing Medical University trials in China

Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention Active, not recruiting

Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome Recruiting

The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM). Starting soon

National Registry and Cohort Study of Pulmonary Vascular Disease Recruiting

Application of CLCVP Technique in Early Intervention of CSA-AKI Recruiting

Other trials for the same condition

Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds Recruiting

Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis Recruiting

Shanghai Prospective Registry Study of Ischemic Stroke Recruiting

Brachial Versus Femoral Access for Carotid Artery Stenting Recruiting

Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05410457 on ClinicalTrials.gov ↗ ← All trials in China